CODX Operating Income from 2010 to 2024

CODX Stock

USD 1.01 0.05 4.72%

Co Diagnostics Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Co Diagnostics generates from its operations. View All Fundamentals

Operating Income

First Reported

2015-12-31

Previous Quarter

-10.2 M

Current Value

-10.2 M

Quarterly Volatility

7.6 M

Yuan Drop

Covid

Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.

Check out the analysis of Co Diagnostics Correlation against competitors.

For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Operating Income Growth Pattern

Below is the plot of the Operating Income of Co Diagnostics over the last few years. Operating Income is the amount of profit realized from Co Diagnostics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Co Diagnostics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Co Diagnostics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Operating Income

Timeline

CODX Operating Income Regression Statistics

	Arithmetic Mean	(2,167,553)
	Coefficient Of Variation	(1,068)
	Mean Deviation	13,125,167
	Median	(1,687,966)
	Standard Deviation	23,144,132
	Sample Variance	535.7T
	Range	88.8M
	R-Value	(0.19)
	Mean Square Error	556T
	R-Squared	0.04
	Significance	0.50
	Slope	(983,113)
	Total Sum of Squares	7499.1T

CODX Operating Income History

	2024	-40.6 M
	2023	-42.7 M
	2022	-11.6 M
	2021	46.1 M
	2020	41.7 M
	2019	-5.9 M
	2018	-6.1 M

Other Fundumenentals of Co Diagnostics

Non Operating Income Net Other

Co Diagnostics Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Debt	Net Receivables	Long Term Debt Total	Short Long Term Debt	Short Term Debt	Current Deferred Revenue	Deferred Long Term Liab	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		1.0	0.89	0.89	0.69	0.84	0.9	0.99	-0.24	0.81	-0.86	0.79	-0.54	0.43	0.42	0.72	0.48	0.99	0.42	0.98	0.93
Total Stockholder Equity	1.0		0.89	0.89	0.7	0.84	0.87	0.99	-0.23	0.82	-0.84	0.77	-0.54	0.42	0.4	0.75	0.47	0.99	0.45	0.99	0.94
Net Tangible Assets	0.89	0.89		0.71	0.93	0.98	0.73	0.88	-0.28	0.97	-0.66	0.55	-0.71	0.47	0.34	0.94	0.43	0.93	0.57	0.91	0.98
Retained Earnings	0.89	0.89	0.71		0.48	0.59	0.82	0.9	0.02	0.6	-0.84	0.82	-0.19	0.14	0.23	0.53	0.22	0.89	0.24	0.91	0.73
Accounts Payable	0.69	0.7	0.93	0.48		0.94	0.5	0.67	-0.23	0.97	-0.37	0.23	-0.71	0.41	0.12	0.96	0.27	0.75	0.52	0.72	0.87
Capital Surpluse	0.84	0.84	0.98	0.59	0.94		0.68	0.82	-0.38	0.98	-0.57	0.44	-0.8	0.55	0.35	0.93	0.48	0.88	0.53	0.85	0.96
Total Liab	0.9	0.87	0.73	0.82	0.5	0.68		0.87	-0.29	0.64	-0.9	0.84	-0.48	0.45	0.5	0.47	0.49	0.87	0.14	0.85	0.75
Total Current Assets	0.99	0.99	0.88	0.9	0.67	0.82	0.87		-0.25	0.78	-0.88	0.82	-0.53	0.44	0.46	0.73	0.51	0.99	0.5	0.99	0.93
Common Stock	-0.24	-0.23	-0.28	0.02	-0.23	-0.38	-0.29	-0.25		-0.3	0.21	-0.17	0.72	-0.78	-0.51	-0.27	-0.49	-0.24	-0.31	-0.24	-0.3
Property Plant Equipment	0.81	0.82	0.97	0.6	0.97	0.98	0.64	0.78	-0.3		-0.5	0.36	-0.74	0.48	0.2	0.94	0.33	0.86	0.46	0.82	0.94
Net Debt	-0.86	-0.84	-0.66	-0.84	-0.37	-0.57	-0.9	-0.88	0.21	-0.5		-0.98	0.36	-0.32	-0.65	-0.42	-0.59	-0.83	-0.34	-0.85	-0.7
Net Receivables	0.79	0.77	0.55	0.82	0.23	0.44	0.84	0.82	-0.17	0.36	-0.98		-0.24	0.26	0.65	0.31	0.58	0.75	0.35	0.79	0.6
Long Term Debt Total	-0.54	-0.54	-0.71	-0.19	-0.71	-0.8	-0.48	-0.53	0.72	-0.74	0.36	-0.24		-0.89	-0.54	-0.71	-0.57	-0.56	-0.52	-0.54	-0.69
Short Long Term Debt	0.43	0.42	0.47	0.14	0.41	0.55	0.45	0.44	-0.78	0.48	-0.32	0.26	-0.89		0.59	0.45	0.5	0.43	0.4	0.42	0.5
Short Term Debt	0.42	0.4	0.34	0.23	0.12	0.35	0.5	0.46	-0.51	0.2	-0.65	0.65	-0.54	0.59		0.2	0.82	0.39	0.49	0.42	0.41
Current Deferred Revenue	0.72	0.75	0.94	0.53	0.96	0.93	0.47	0.73	-0.27	0.94	-0.42	0.31	-0.71	0.45	0.2		0.32	0.79	0.69	0.78	0.91
Deferred Long Term Liab	0.48	0.47	0.43	0.22	0.27	0.48	0.49	0.51	-0.49	0.33	-0.59	0.58	-0.57	0.5	0.82	0.32		0.46	0.57	0.47	0.49
Net Invested Capital	0.99	0.99	0.93	0.89	0.75	0.88	0.87	0.99	-0.24	0.86	-0.83	0.75	-0.56	0.43	0.39	0.79	0.46		0.45	0.99	0.95
Long Term Investments	0.42	0.45	0.57	0.24	0.52	0.53	0.14	0.5	-0.31	0.46	-0.34	0.35	-0.52	0.4	0.49	0.69	0.57	0.45		0.51	0.6
Net Working Capital	0.98	0.99	0.91	0.91	0.72	0.85	0.85	0.99	-0.24	0.82	-0.85	0.79	-0.54	0.42	0.42	0.78	0.47	0.99	0.51		0.94
Capital Stock	0.93	0.94	0.98	0.73	0.87	0.96	0.75	0.93	-0.3	0.94	-0.7	0.6	-0.69	0.5	0.41	0.91	0.49	0.95	0.6	0.94

Click cells to compare fundamentals

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-42.7 M	-40.6 M
Non Operating Income Net Other	9.4 M	9.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CODX Operating Income from 2010 to 2024

Latest Co Diagnostics' Operating Income Growth Pattern

CODX Operating Income Regression Statistics

CODX Operating Income History

Other Fundumenentals of Co Diagnostics

Co Diagnostics Operating Income component correlations

About Co Diagnostics Financial Statements

Also Currently Popular

Additional Tools for CODX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY